Top Most 15+ What Does Trillium Therapeutics Do
-
1.Pfizer To Acquire Trillium Therapeutics Inc.
Aug 23, 2021
View more » -
2.Pfizer Completes Acquisition Of Trillium Therapeutics
Nov 17, 2021 · As Trillium becomes part of Pfizer, it brings an impressive portfolio that includes biologics that are designed to enhance the ability of ...
View more » -
3.Trillium Therapeutics Inc - Company Profile And News
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company. The Company develops therapies for the treatment of cancer and has preclinical ...
View more » -
4.Pfizer Agrees To Acquire Trillium Therapeutics For $2.26bn
Aug 24, 2021 · Pfizer signed a definitive agreement to acquire all outstanding shares of Trillium Therapeutics for a proposed equity value of $2.26bn.
View more » -
5.Trillium Therapeutics Inc. - LinkedIn
Oct 8, 2020 · (NASDAQ/TSX:TRIL) is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. We have a strong ...
View more » -
6.Pfizer To Acquire Trillium Therapeutics Inc. - GlobeNewswire
Aug 23, 2021 · Pfizer to Acquire Trillium Therapeutics Inc. · Proposed acquisition strengthens Pfizer's category leadership in Oncology with addition of next- ...
View more » -
7.Pfizer To Acquire Trillium Therapeutics In $2.26-Billion Deal
Aug 25, 2021 · Pfizer's proposed $2.26-billion acquisition of Trillium Therapeutics will add next-generation hematology-targeted immuno-therapeutics to its ...
View more » -
8.UPDATE: Pfizer And Trillium: How A $25M Investment Led To A $2.3B ...
2 days ago · Pfizer was in a hurry to seal its takeover of cancer startup Trillium Therapeutics, a relationship that was first sparked after the Big ...
View more » -
9.Trillium Therapeutics - Crunchbase Company Profile & Funding
Trillium is a biotech company focused on developing therapy treatments for cancer.
View more » -
10.Trillium Therapeutics Inc.
Trillium is a research and development company specializing in innovative therapies that restore balance to the immune system in conditions associated with ...
View more » -
11.Why Trillium Therapeutics Stock Is Skyrocketing Today
Aug 23, 2021 · Shares of the developmental-stage biotech Trillium Therapeutics (TRIL) are up by a whopping 192% in pre-market trading Monday morning.
View more » -
12.Why Investors Should Love Pfizer's Acquisition Of Trillium
Sep 4, 2021 · Pfizer plans to acquire Trillium Therapeutics for nearly $2.3 billion. · Trillium's pipeline fits really well with Pfizer's oncology programs.
View more » -
13.Trillium Therapeutics Inc.
Trillium Therapeutics Inc. (NASDAQ/TSX:TRIL) is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer.
View more » -
14.Pfizer To Buy Cancer Drug Developer Trillium In $2.3 Bln Deal | Reuters
Aug 23, 2021 · Pfizer Inc said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc in a $2.26 billion deal to strengthen its arsenal ...
View more » -
15.Pfizer Agrees To Buy Cancer Biotech Trillium Therapeutics At A 200 ...
Aug 23, 2021 · Pfizer said early Monday that it had agreed to purchase cancer-focused biotech Trillium Therapeutics for $2.3 billion in cash, or $18.50 a ...
View more »